Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis-Reference-Cited by-同舟云学术

Comorbidity burden and clinical characteristics of patients with difficult-to-control rheumatoid arthritis

Published:2019-05-10 Issue:9 Volume:38 Page:2473-2481
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Batko Bogdan^ORCID,Urbański Karol,Świerkot Jerzy,Wiland Piotr,Raciborski Filip,Jędrzejewski Mariusz,Koziej Mateusz,Cześnikiewicz-Guzik Marta,Guzik Tomasz J.,Stajszczyk Marcin

Funder

Roche

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s10067-019-04579-1.pdf

Reference22 articles.

1. Roodenrijs NMT, de Hair MJH, van der Goes MC, Jacobs JWG, Welsing PMJ, van der Heijde D, Aletaha D, Dougados M, Hyrich KL, McInnes IB, Mueller-Ladner U, Senolt L, Szekanecz Z, van Laar JM, Nagy G, On behalf of the whole EULAR Task Force on development of EULAR recommendations for the comprehensive management of difficult-to-treat rheumatoid arthritis (2018) Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey. Ann Rheum Dis 77:1705–1709. https://doi.org/10.1136/annrheumdis-2018-213687

2. Kaló Z, Vokó Z, Östör A, Clifton-Brown E, Vasilescu R, Battersby A, Gibson E (2017) Patient access to reimbursed biological disease-modifying antirheumatic drugs in the European region. J Mark Access Health Policy 5:1345580. https://doi.org/10.1080/20016689.2017.1345580

3. Batko B, Stajszczyk M, Świerkot J, Urbański K, Raciborski F, Jędrzejewski M, Wiland P (2019) Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study. Arch Med Sci 15:134–140. https://doi.org/10.5114/aoms.2017.71371

4. Kapetanovic M, Lindqvist E, Simonsson M, Geborek P, Saxne T, Eberhardt K (2010) Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20 years: lack of association between inflammation and cardiovascular disease. Scand J Rheumatol 39:353–359. https://doi.org/10.3109/03009741003674180

5. Innala L, Berglin E, Möller B, Ljung L, Smedby T, Södergren A, Magnusson S, Rantapää-Dahlqvist S, Wållberg-Jonsson S (2014) Age at onset determines severity and choice of treatment in early rheumatoid arthritis: a prospective study. Arthritis Res Ther 16:R94. https://doi.org/10.1186/ar4540

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry;Arthritis Research & Therapy;2024-07-26

2. Impact of Orthopedic Surgical Interventions on Difficult-to-Treat Rheumatoid Arthritis (D2T RA): A Propensity Score Matched Study;2024-04-05

3. Current and Future Challenges for Rehabilitation for Inflammatory Arthritis;Journal of Clinical Medicine;2024-03-21

4. Predictors of functional improvement and pain reduction in rheumatoid arthritis patients who achieved low disease activity with disease-modifying antirheumatic drugs: a retrospective study of the FIRST Registry;2024-03-12

5. Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy;The Journal of Rheumatology;2024-02-01